BC
IDXX icon

Brinker Capital’s Idexx Laboratories IDXX Stock Holding History

Brinker Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$784K Buy
2,375
+53
+2% +$15.3K 0.03% 573
2020
Q1 		$562K Sell
2,322
-66
-3% -$17.2K 0.02% 603
2019
Q4 		$624K Sell
2,388
-114
-5% -$30K 0.02% 654
2019
Q3 		$680K Sell
2,502
-41
-2% -$11.4K 0.02% 612
2019
Q2 		$700K Sell
2,543
-351
-12% -$86.5K 0.03% 595
2019
Q1 		$647K Buy
2,894
+981
+51% +$203K 0.02% 605
2018
Q4 		$356K Sell
1,913
-71
-4% -$14.6K 0.02% 694
2018
Q3 		$495K Buy
1,984
+39
+2% +$9.47K 0.02% 724
2018
Q2 		$424K Sell
1,945
-3,741
-66% -$771K 0.02% 760
2018
Q1 		$1.09M Buy
5,686
+1,977
+53% +$365K 0.04% 448
2017
Q4 		$580K Sell
3,709
-15
-0.4% -$2.36K 0.02% 641
2017
Q3 		$579K Buy
+3,724
New +$589K 0.02% 614
2017
Q2 		– Sell
-8,445
Closed -$1.31M – 759
2017
Q1 		$1.31M Buy
8,445
+4,519
+115% +$623K 0.06% 294
2016
Q4 		$460K Buy
+3,926
New +$448K 0.03% 475

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Brinker Capital's IDXX Position: Q2 2020 in Review

Brinker Capital increased its Idexx Laboratories (IDXX) stake by 2.3% in Q2 2020, buying an estimated $15.3K and bringing the position to 2,375 shares worth $784K. The position accounts for 0.03% of the portfolio, ranked #573.

Brinker Capital first reported a position in IDXX in Q4 2016 and has held it in 14 quarters since. The position peaked at $1.31M in Q1 2017. 802 funds tracked by Wall St. Rank hold IDXX as of Q2 2020.

  • Brinker Capital held 2,375 shares of Idexx Laboratories worth $784K as of Q2 2020.
  • Brinker Capital bought 53 Idexx Laboratories shares in Q2 2020, an estimated $15.3K.
  • Idexx Laboratories made up 0.03% of Brinker Capital's portfolio in Q2 2020, its #573 holding.
  • Brinker Capital first reported a position in Idexx Laboratories in Q4 2016 and has held it in 14 quarters since.
  • Brinker Capital's Idexx Laboratories position peaked at $1.31M in Q1 2017.
  • 802 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.